These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 5580287)

  • 21. Photochemotherapy of vitiligo. Use of orally administered psoralens and a high-intensity long-wave ultraviolet light system.
    Parrish JA; Fitzpatrick TB; Shea C; Pathak MA
    Arch Dermatol; 1976 Nov; 112(11):1531-4. PubMed ID: 984858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vitiligo treatment.
    Ortel B; Tanew A; Hönigsmann H
    Curr Probl Dermatol; 1986; 15():265-71. PubMed ID: 3948525
    [No Abstract]   [Full Text] [Related]  

  • 23. Determination of optimal topical photochemotherapy for vitiligo.
    Grimes PE; Minus HR; Chakrabarti SG; Enterline J; Halder R; Gough JE; Kenney JA
    J Am Acad Dermatol; 1982 Dec; 7(6):771-8. PubMed ID: 7174915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of vitiligo with topical methoxsalen and blacklite.
    Fulton JE; Leyden J; Papa C
    Arch Dermatol; 1969 Aug; 100(2):224-9. PubMed ID: 5797966
    [No Abstract]   [Full Text] [Related]  

  • 25. Trimethoxypsoralen in vitiligo.
    Annamalai R; Subhan SA; Vasantha M; Lal MB
    Int J Dermatol; 1976 Nov; 15(9):690-3. PubMed ID: 977211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How we treat vitiligo.
    Kenney JA; Grimes PE
    Cutis; 1983 Oct; 32(4):347-8. PubMed ID: 6627994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topical prostaglandin analog (PGE2) in vitiligo--a preliminary study.
    Parsad D; Pandhi R; Dogra S; Kumar B
    Int J Dermatol; 2002 Dec; 41(12):942-5. PubMed ID: 12492997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral mini-pulse therapy with betamethasone in vitiligo patients having extensive or fast-spreading disease.
    Pasricha JS; Khaitan BK
    Int J Dermatol; 1993 Oct; 32(10):753-7. PubMed ID: 8225724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flavonoids as adjuvant in psoralen based photochemotherapy in the management of vitiligo/leucoderma.
    Shivasaraun UV; Sureshkumar R; Karthika C; Puttappa N
    Med Hypotheses; 2018 Dec; 121():26-30. PubMed ID: 30396481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical tacrolimus is more effective for treatment of vitiligo in patients of skin of color.
    Silverberg JI; Silverberg NB
    J Drugs Dermatol; 2011 May; 10(5):507-10. PubMed ID: 21533297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment acquired vitiligo with Beroxan].
    Rudowska I
    Przegl Dermatol; 1969; 56(2):225-9. PubMed ID: 5790582
    [No Abstract]   [Full Text] [Related]  

  • 32. Topical tacrolimus for treatment of childhood vitiligo in Asians.
    Kanwar AJ; Dogra S; Parsad D
    Clin Exp Dermatol; 2004 Nov; 29(6):589-92. PubMed ID: 15550128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Basic evidence for epidermal H2O2/ONOO(-)-mediated oxidation/nitration in segmental vitiligo is supported by repigmentation of skin and eyelashes after reduction of epidermal H2O2 with topical NB-UVB-activated pseudocatalase PC-KUS.
    Schallreuter KU; Salem MA; Holtz S; Panske A
    FASEB J; 2013 Aug; 27(8):3113-22. PubMed ID: 23629861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An approach to the treatment of vitiligo by khellin.
    Abdel-Fattah A; Aboul-Enein MN; Wassel GM; El-Menshawi BS
    Dermatologica; 1982 Aug; 165(2):136-40. PubMed ID: 6754485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral dosage in methoxsalen phototoxicity.
    Kligman AM; Goldstein FP
    Arch Dermatol; 1973 Apr; 107(4):548-50. PubMed ID: 4697683
    [No Abstract]   [Full Text] [Related]  

  • 36. Localized vitiligo successfully treated with cream-psoralen + ultraviolet A.
    Kreuter A; Gambichler T; Avermaete A; Jansen T; Altmeyer P; von Kobyletzki G
    J Eur Acad Dermatol Venereol; 2001 Jul; 15(4):357-8. PubMed ID: 11730053
    [No Abstract]   [Full Text] [Related]  

  • 37. Cutaneous malignancies in patients treated with psoralen photochemotherapy (PUVA) for vitiligo.
    Halder RM; Battle EF; Smith EM
    Arch Dermatol; 1995 Jun; 131(6):734-5. PubMed ID: 7778934
    [No Abstract]   [Full Text] [Related]  

  • 38. [Experience in the use of a psoberan preparation in patients with vitiligo and alopecia].
    Braĭtsev AV
    Vestn Dermatol Venerol; 1975 Sep; (9):53-5. PubMed ID: 1231363
    [No Abstract]   [Full Text] [Related]  

  • 39. Optimal weekly frequency of 308-nm excimer laser treatment in vitiligo patients.
    Hofer A; Hassan AS; Legat FJ; Kerl H; Wolf P
    Br J Dermatol; 2005 May; 152(5):981-5. PubMed ID: 15888156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Repigmentation of vitiligo during efalizumab.
    Wakkee M; Assen YJ; Thio HB; Neumann HA
    J Am Acad Dermatol; 2008 Aug; 59(2 Suppl 1):S57-8. PubMed ID: 18625392
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.